ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $344 | -27.1% | 12,837 | -3.1% | 0.00% | -33.3% |
| Q2 2023 | $472 | +24.5% | 13,252 | -11.2% | 0.01% | +50.0% |
| Q1 2023 | $379 | -36.3% | 14,923 | +1.6% | 0.00% | -42.9% |
| Q4 2022 | $595 | -99.9% | 14,688 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $485,000 | -9.2% | 14,688 | -3.2% | 0.01% | 0.0% |
| Q2 2022 | $534,000 | -21.7% | 15,173 | +2.2% | 0.01% | 0.0% |
| Q1 2022 | $682,000 | -31.8% | 14,843 | -1.7% | 0.01% | -30.0% |
| Q4 2021 | $1,000,000 | +0.1% | 15,093 | -5.7% | 0.01% | 0.0% |
| Q3 2021 | $999,000 | -25.4% | 16,003 | -1.0% | 0.01% | -28.6% |
| Q2 2021 | $1,339,000 | +24.2% | 16,172 | -0.6% | 0.01% | +16.7% |
| Q1 2021 | $1,078,000 | -15.8% | 16,262 | -2.6% | 0.01% | -20.0% |
| Q4 2020 | $1,280,000 | +70.4% | 16,694 | -4.4% | 0.02% | +66.7% |
| Q3 2020 | $751,000 | -3.8% | 17,457 | -3.5% | 0.01% | -10.0% |
| Q2 2020 | $781,000 | +57.5% | 18,097 | +4.9% | 0.01% | +25.0% |
| Q1 2020 | $496,000 | -52.4% | 17,251 | +4.8% | 0.01% | -42.9% |
| Q4 2019 | $1,043,000 | -49.4% | 16,455 | -77.5% | 0.01% | -50.0% |
| Q3 2019 | $2,063,000 | +141.3% | 73,212 | +126.9% | 0.03% | +100.0% |
| Q2 2019 | $855,000 | – | 32,265 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |